
Izberite svojo etiketo
prikazano neposredno na vialiBPC + TB + KPV Blend
Healing
- Odprema iz Nemčije
Naročilo
- DHL s sledenjem
- Diskretna embalaža
Na prvi pogled
BPC + TB + KPV Blend v številkah
Ključni podatki iz našega leksikona.
Celoten vnos v leksikonu- Class
- Healing blendBPC + TB + KPV
- Use
- Subcutaneousin mg, a third each
- Sizes
- 30 mg1 size in the shop
What studies show
The source in the lexicon- Dalmasso et al., Gastroenterology, 2008
Za BPC + TB + KPV Blend še ni laboratorijske analize. Glasujte zanjDajte testirati sami, mi plačamo polovicoVse laboratorijske analize
Znanje
Vse o BPC + TB + KPV Blend
Podrobne informacije bodo kmalu na voljo.
Odmerjanje
Nalaganje podatkov o odmerjanju …
Priporočljivo zraven
Kaj potrebujete zraven
Bakteriostatska voda se samodejno doda v vašo košarico. Brizge in robčki z enim klikom.
Inzulinske brizge
10 kos. · 5.50 €
Alkoholni robčki
50 kos. · 10 €
Koliko vode?
Enote na brizgi za vašo velikost viale.
Odpri kalkulator →Are there studies on this blend?
No. As of 26 October 2026 ClinicalTrials.gov lists no trial with KPV and none with two of the three components together. Everything here comes from studies on the single compounds.
What is KPV supposed to add to the blend?
KPV is the last three building blocks of alpha-MSH. The transporter PepT1 carries it into gut and immune cells, where it inhibits the NF-κB and MAP kinase pathways even at nanomolar amounts. In colitis models in mice KPV in the drinking water reduced inflammation, also in animals without a functional MC1R. Whether it adds anything when injected together with BPC-157 and TB-500 has not been tested.
Do BPC-157 and TB-500 work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, above all TB-500. The combination gave no advantage over either alone. KPV was not part of this study.
What do the studies on the single components show?
With KPV drops all 8 corneal wounds closed in rabbits within 60 hours, none with placebo. Thymosin beta-4 sped up wound closure in rats by up to 61 percent. BPC-157 promoted new blood vessels via the receptor VEGFR2. All animal and cell studies.
Which human studies exist?
None on KPV. For BPC-157 three small studies with 30 people in total, all without a control group, plus a planned phase 1 trial. Thymosin beta-4 was tested into a vein in healthy adults and in phase 2 after heart attack.
Which side effects are known?
None for the blend. The three human studies on BPC-157 saw no treatment-related side effects, with very low certainty. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. For KPV human data are missing entirely.
Sorodno
Sorodni izdelki
BPC-157
Peptidi · Celjenje in regeneracija Celjenje in regeneracija
4 velikosti
Laboratorijsko testirano
= od 5.2 €/vialo
TB-500 (Thymosin B4)
Peptidi · Celjenje in regeneracija Celjenje in regeneracija
3 velikosti
Laboratorijsko testirano
= od 18.8 €/vialo
TB-500 FRAG
Peptidi · Celjenje in regeneracija Celjenje in regeneracija
1 velikost
= 24.8 €/vialo
BPC + TB Blend
Peptidi · Celjenje in regeneracija Celjenje in regeneracija
3 velikosti
Laboratorijsko testirano
= od 24.8 €/vialo
BPC + TB + KPV Blend